anmelden
NASDAQ 100
28.295,51
PKT
+189,16
PKT
+0,67
%
Indikation*
28.274,20
PKT
+167,85
PKT
+0,60
%
Offiziell
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NASDAQ 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.11.17 | Alnylam Pharmaceuticals overweight | Barclays Capital | |
| 08.11.17 | Axon Enterprise Buy | Dougherty & Company LLC | |
| 08.11.17 | Take Two Outperform | Robert W. Baird & Co. Incorporated | |
| 08.11.17 | Walmart neutral | Morgan Stanley | |
| 08.11.17 | Intel Hold | Morningstar | |
| 08.11.17 | Take Two Buy | The Benchmark Company | |
| 08.11.17 | Alnylam Pharmaceuticals Buy | B. Riley FBR, Inc. | |
| 08.11.17 | Gilead Sciences Buy | Mizuho | |
| 08.11.17 | QUALCOMM Outperform | RBC Capital Markets | |
| 07.11.17 | Booking Buy | Stifel, Nicolaus & Co., Inc. | |
| 07.11.17 | Monolithic Power Systems Buy | Stifel, Nicolaus & Co., Inc. | |
| 07.11.17 | Microchip Technology Buy | Stifel, Nicolaus & Co., Inc. | |
| 07.11.17 | Intel Outperform | Wells Fargo & Co | |
| 07.11.17 | Booking Outperform | RBC Capital Markets | |
| 07.11.17 | T-Mobile US buy | Jefferies & Company Inc. | |
| 07.11.17 | Microchip Technology Strong Buy | Needham & Company, LLC | |
| 07.11.17 | Booking Buy | Needham & Company, LLC | |
| 06.11.17 | QUALCOMM Hold | Standpoint Research | |
| 06.11.17 | Apple buy | UBS AG | |
| 06.11.17 | Automatic Data Processing Sector Perform | RBC Capital Markets | |
| 06.11.17 | T-Mobile US buy | UBS AG | |
| 06.11.17 | NVIDIA Buy | B. Riley FBR, Inc. | |
| 03.11.17 | Intel Outperform | BMO Capital Markets | |
| 03.11.17 | Apple buy | UBS AG | |
| 03.11.17 | Apple overweight | Atlantic Equities | |
| 03.11.17 | Apple Outperform | Macquarie Research | |
| 03.11.17 | Apple buy | Needham & Company, LLC | |
| 03.11.17 | Apple Outperform | Bernstein Research | |
| 03.11.17 | Apple buy | Nomura | |
| 03.11.17 | Apple overweight | Morgan Stanley | |
| 03.11.17 | Apple Outperform | RBC Capital Markets | |
| 03.11.17 | Alnylam Pharmaceuticals Buy | Needham & Company, LLC | |
| 02.11.17 | Alnylam Pharmaceuticals Buy | B. Riley FBR, Inc. | |
| 02.11.17 | Broadcom Buy | B. Riley FBR, Inc. | |
| 02.11.17 | Meta Platforms (ex Facebook) overweight | Morgan Stanley | |
| 02.11.17 | Meta Platforms (ex Facebook) Outperform | RBC Capital Markets | |
| 02.11.17 | Meta Platforms (ex Facebook) Outperform | Credit Suisse Group | |
| 02.11.17 | Meta Platforms (ex Facebook) buy | UBS AG | |
| 02.11.17 | Meta Platforms (ex Facebook) overweight | Atlantic Equities | |
| 02.11.17 | Meta Platforms (ex Facebook) Outperform | Macquarie Research |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.